Early markers of alzheimer's disease: pet radiotracer acquisition in the baltimore longitudinal study of aging (blsa)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95023D00013
- Awardee
-
Lantheus Biosciences LTD. UEI FKMRJTNYMPZ1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 5 $339,900 obligated
Award facts
- Opportunity
-
- Early Markers of Alzheimer’s Disease: PET Radiotracer Acquisition in the Baltimore Longitudinal Study of Aging (BLSA) Pre-Solicitation · 75N95023Q00150 · Posted Dec 13, 2022
- Combined order value
- $339,900 Current and potential, with all options
- Last date to order 62% complete
- IDV ceiling 18% used
- $1,900,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health National Institute on Aging awarded a single award indefinite delivery contract to Life Molecular Imaging Limited with a potential value of $1,900,000. Task orders issued to date include $86,000 for tau protein positron emission tomography imaging services and $60,000 for amyloid doses. Both task orders are firm fixed price, for one-year periods of performance from September 2023 through September 2024. Life Molecular Imaging Limited will perform the work out of its Sterling, Virginia location.
The original solicitation sought sources for acquisition of FDA-approved amyloid and second generation tau positron emission tomography radioligand doses to measure brain pathology as part of the Baltimore Longitudinal Study of Aging. The National Institute on Aging requires these doses to further its mission of understanding the nature of aging and extending healthy lifespans by characterizing individual differences in longitudinal brain changes through molecular imaging techniques. Responses assisted in determining an appropriate acquisition method supporting the National Institute on Aging's research goals within the study period outlined.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95023D00013?
75N95023D00013 was awarded to Lantheus Biosciences LTD. by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2023.
How much is contract 75N95023D00013 worth?
Orders under 75N95023D00013 have obligated $339,900. 75N95023D00013's own ceiling is $1,900,000.
How many orders have been placed under contract 75N95023D00013?
5 orders have been placed under 75N95023D00013, the latest on September 15, 2025.
Which agency awarded contract 75N95023D00013?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023D00013, with funding from National Institute on Aging (National Institutes of Health).
Who can order from contract 75N95023D00013?
75N95023D00013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95023D00013 competed?
The extent of competition for 75N95023D00013 was competed under sap. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV